Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ricci

Showing results (291-300 of 595) with videos related to

Pageof 60
Sort By:
Leukemia|July 30, 2013
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potentialL M Neri, A Cani, A M Martelli, et al.
Nature Geoscience|September 15, 2025
Coastal methane emissions driven by aerotolerant methanogens using seaweed and seagrass metabolitesN Hall, W W Wong, R Lappan, et al.
European Cells & Materials|July 3, 2010
A recently developed bifacial platelet-rich fibrin matrixE Lucarelli, R Beretta, B Dozza, et al.
Neotropical Entomology|July 4, 2007
[Susceptibility of six Arabic coffee cultivars to fruit flies (Diptera: Tephritoidea) under shaded and unshaded organic management in Valença, State of Rio de Janeiro, Brazil]Elen L Aguiar-Menezes, Silvana A S Souza, Carlos M A Santos, et al.
European Journal of Haematology|January 26, 1999
Antibodies reactive with neutrophils following allogeneic haematopoietic stem cell transplantationP L Tazzari, D Rondelli, F Re, et al.
ESMO Open|September 15, 2022
Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumorsC Le Tourneau, H Becker, R Claus, et al.
Leukemia|February 19, 2011
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemiaC Evangelisti, F Ricci, P Tazzari, et al.
Leukemia|October 12, 2007
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cellsV Papa, P L Tazzari, F Chiarini, et al.
Clinical and Experimental Immunology|January 24, 2004
Expression of CTLA-4 in nonhuman primate lymphocytes and its use as a potential target for specific immunotoxin-mediated apoptosis: results of in vitro studiesG L Palmisano, P L Tazzari, E Cozzi, et al.
Eye (London, England)|September 16, 2017
Assessing individual risk for AMD with genetic counseling, family history, and genetic testingR Cascella, C Strafella, G Longo, et al.
Pageof 60

Showing results (291-300 of 595) with videos related to

Sort By:
Pageof 60
Leukemia|July 30, 2013
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potentialL M Neri, A Cani, A M Martelli, et al.
Nature Geoscience|September 15, 2025
Coastal methane emissions driven by aerotolerant methanogens using seaweed and seagrass metabolitesN Hall, W W Wong, R Lappan, et al.
European Cells & Materials|July 3, 2010
A recently developed bifacial platelet-rich fibrin matrixE Lucarelli, R Beretta, B Dozza, et al.
Neotropical Entomology|July 4, 2007
[Susceptibility of six Arabic coffee cultivars to fruit flies (Diptera: Tephritoidea) under shaded and unshaded organic management in Valença, State of Rio de Janeiro, Brazil]Elen L Aguiar-Menezes, Silvana A S Souza, Carlos M A Santos, et al.
European Journal of Haematology|January 26, 1999
Antibodies reactive with neutrophils following allogeneic haematopoietic stem cell transplantationP L Tazzari, D Rondelli, F Re, et al.
ESMO Open|September 15, 2022
Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumorsC Le Tourneau, H Becker, R Claus, et al.
Leukemia|February 19, 2011
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemiaC Evangelisti, F Ricci, P Tazzari, et al.
Leukemia|October 12, 2007
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cellsV Papa, P L Tazzari, F Chiarini, et al.
Clinical and Experimental Immunology|January 24, 2004
Expression of CTLA-4 in nonhuman primate lymphocytes and its use as a potential target for specific immunotoxin-mediated apoptosis: results of in vitro studiesG L Palmisano, P L Tazzari, E Cozzi, et al.
Eye (London, England)|September 16, 2017
Assessing individual risk for AMD with genetic counseling, family history, and genetic testingR Cascella, C Strafella, G Longo, et al.
Pageof 60